LUPIN
|
The Current P/S Ratio of LUPIN is 3.83.
| Share Price | ₹2,342.2 | Jun 25,2026 |
| Market Cap | ₹107,083.1 Cr | |
| Sales-TTM | ₹27,958.0 Cr | TTM-Consolidated Results |
| Price/Sales | 3.83x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LUPIN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹107,083.1 Cr] as on Jun 25,2026
(/) Sales [ ₹27,958.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.83x ]
Thus, for LUPIN , the investors are currently willing to pay '3.83 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LUPIN !
The chart below summarizes the trend in P/S Ratio of LUPIN over the last five years.
Historical PS (Price/Sales) ratio chart of LUPIN
PS Ratio Performance Analysis for LUPIN
- LUPIN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.93x.
- LUPIN 's operated at median p/e ratio of 3.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/e ratio peaked in Mar2025 at 4.07x.
- LUPIN 's p/e ratio hit its five-year low in Mar2023 of 1.77x.
How does LUPIN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LUPIN | 27,958.0 | 3.83 | 107,083.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.69 | 449,299.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.50 | 174,207.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.28 | 157,721.0 |
| CIPLA LTD | 28,162.6 | 4.17 | 117,420.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.41 | 114,876.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.19 | 102,642.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,885.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.65 | 89,117.4 |
| LAURUS LABS LTD | 6,812.9 | 11.92 | 81,194.1 |
| BIOCON LTD | 16,927.0 | 3.98 | 67,308.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LUPIN 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.65x |
| Max industry PS | 16.50x |
| Median industry PS | 4.17x |
| Average industry PS | 6.97x |
You may also like the below Video Courses